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Abstract
Aneurysms are characterized by dilation, i.e. expansion and thinning of all the arterial wall layers, which is accompanied by
remodeling of the connective tissue. Genes involved in the regulation of tissue remodeling are therefore candidate genes. We
 .analyzed TIMP1 and TIMP2 coding sequences in 12 individuals with abdominal aortic aneurysms AAA , one individual with
 .AAA and intracranial aneurysms IA , four individuals with IA and two clinically unaffected individuals. We identified two
nucleotide variants in both the TIMP1 and the TIMP2 coding sequences. All differences occurred in the third base positions
of codons and were neutral polymorphisms. A significant difference was observed in the frequency of TIMP2 nt 573
polymorphism between 168 alleles from AAA patients and 102 control alleles. Q 1999 Elsevier Science B.V.rInternational
Society of Matrix Biology. All rights reserved.
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1. Introduction
 .Rupture of an abdominal aortic AAA or intracra-
 .nial IA aneurysm is a significant cause of mortality
and morbidity, and 1]6% of the population in the
USA and other industrialized countries harbor
 .aneurysms see Verloes et al., 1996 . Despite the
U Corresponding author.
Abbre¨iations: AAA, abdominal aortic aneurysm; cDNA, comple-
mentary DNA; IA, intracranial aneurysm; PCR, polymerase chain
reaction; TIMP1, tissue inhibitor of metalloproteinase 1; TIMP2,
tissue inhibitor of metalloproteinase 2; nt, nucleotide
major advances in surgical treatment, the survival rate
after a ruptured aneurysm is low. Early diagnosis of
aneurysms is, therefore, important. If it were possible
to predict who is at risk for developing an aneurysm,
diagnostic efforts ultrasonography, computerized to-
.mography and magnetic resonance imaging could be
directed towards those at risk.
Familial predisposition to both AAAs and IAs is
now well recognized see Verloes et al., 1996;
.Ronkainen et al., 1997 . The possible genetic factors
involved in the development of aneurysms include
 .  .see Verloes et al., 1996 : a structural components
 .of arteries; b enzymes degrading the structural
 .molecules; and c inhibitors of the proteolytic process.
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DNA sequencing of 50 aortic aneurysm patients
 .Tromp et al., 1993 and 55 IA or carotid artery
 .dissection patients Kuivaniemi et al., 1993 revealed
that mutations in type III procollagen are an infre-
quent cause of aneurysms.
The development of aneurysms is associated with
remodeling of the extracellular matrix, including
breakdown of structural components of the vascular
 .wall see Verloes et al., 1996 . Collagenase activity
 .and production of 92-kDa gelatinase MMP9 are
increased in ruptured aneurysmal aorta see Verloes
.et al., 1996 . The increased proteolytic activity could
be due to overexpression of the enzymes or down-reg-
ulation of their inhibitors. In fact, decreased levels of
 .tissue inhibitors of metalloproteinases TIMPs in
 .AAAs have been reported see Verloes et al., 1996 .
Furthermore, the ratio of matrix metalloproteinase
 .MMP mRNA amount to TIMP mRNA was higher
 .in AAA than in normal aortas Tamarina et al., 1997 .
The relative TIMP deficiency could be due to local
tissue conditions inhibiting the expression or muta-
tions in the primary structure of the TIMP genes.
There are at least four members in the TIMP family,
all of which were cloned, sequenced and mapped onto
 .human chromosomes see Olson et al., 1998 .
We studied the coding sequences of TIMP1 and
TIMP2 in patients with AAA andror IA to determine
whether mutations in the TIMP genes are associated
with aneurysms.
2. Materials and methods
This study was initiated at Thomas Jefferson Uni-
versity and was approved by the Institutional Review
Committees of Thomas Jefferson University and
Wayne State University School of Medicine. Skin
biopsies obtained after written informed consent were
used to establish fibroblast cultures. RNA was isolated,
cDNA synthesized, PCR products purified and
genomic DNA isolated as described previously Tromp
.et al., 1993 . Oligonucleotide primers based on the
cDNA sequences of TIMP1 TIMP1-I, CGC-
GAATTCAGATCCAGCGCCCAGAGAG; TIMP1-
II, CGCGGATCCGGAAGAAAGATGGGAG-
. TGGG; Docherty et al., 1985 and TIMP2 TIMP2-II,
TTTATTCATGCTGTTTCCAGGAAGGG; TIMP2-
VI, CGGCCCCGCCCGCCCAGC; Stetler-Stevenson
.et al., 1990 were used in PCR to amplify all the
coding sequences. Because of the high GC content in
the 59 end of the TIMP2, many PCR conditions
failed, but Q-solution and Qiagen PCR kit were used
 .successfully Qiagen Inc., Santa Clarita, CA, USA .
The PCR products were sequenced directly using
W either Sequenase US Biochemical Corporation,
. w 3 3 xCleveland, O H , U SA and a - P dA TP
 . W NENrDuPont , or Thermo Sequenase Amersham
.Life Science, Inc., Cleveland, OH, USA . The samples
W were electrophoresed on a Sequagel-6 National Di-
.agnostics, Atlanta, GA, USA or on glycerol-tolerant
gels Amersham Life Science, Inc., Cleveland, OH,
.USA .
The sequence variants were confirmed by PCR-
based restriction endonuclease assays. The gender of
all samples was confirmed by Y-chromosome specific
 .PCR Research Genetics, Huntsville, AL, USA . For
genomic PCRs, primers were designed based on pub-
lished sequences Genbank accession number D11139;
.Hammani et al., 1996 . Primer sequences and PCR
conditions are available from the corresponding au-
thor upon request.
3. Results and discussion
To investigate the possibility that aneurysms are
caused by defects in the genes for TIMP1 or TIMP2,
the sequences of the coding regions of TIMP1 and
TIMP2 were determined in 19 unrelated individuals
12 had AAA, one had AAA and IA, four had IA, and
.two were clinically unaffected . All except one of the
17 aneurysm patients had a family history for the
disease. The type III procollagen cDNA sequences in
all of these individuals were normal Kuivaniemi et
.al., 1993; Tromp et al., 1993 .
The sequence analyses carried out here provided
671 nt of TIMP1 cDNA sequences all 621 nt of
.coding sequences from each individual. Two se-
quence variations were found. AAA patient JIMM429
had CrT nt 323 proline codon at amino acid position
.87 changes from CCC to CCT . All the other 18
individuals had C at nt 323. Another sequence change
was found at nt 434, also reported by others Tilson et
.al., 1993 . Six individuals had C at this site, 11 had T
and two individuals were heterozygous CrT. The se-
quence change converted the phenylalanine codon
TTC at amino acid position 124 to TTT.
For TIMP2, we analyzed 750-nt all 660 nt of cod-
.ing sequences , and two sequence variations were
identified. AAA patient JIMM398 had CrT at nt 306.
Another difference, G to A transition, occurred at nt
573 in three patients JIMM332, JIMM430 and
.JIMM257 , all of whom were heterozygous for this
change. Both variations occurred at the third posi-
tions of codons and did not change the amino acids.
The frequencies of these variations were de-
termined among 102 control alleles and 168 alleles
from AAA patients 11 of the patients used for DNA
sequencing and 73 additional unrelated AAA
.patients . The TIMP1 gene includes four exons
 .Genbank accession number: D11139 , and the vari-
ants are in the second and third exons. Since TIMP1
is on the X chromosome, we report the allele fre-
 .quencies separately in males and females Table 1 .
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Table 1
Frequencies of the polymorphisms in TIMP1 and TIMP2 genes
a b cLocation Chr. Controls Unrelated AAA patients
d d fAllele frequency Allele frequency P-value
e eM F Het. M F Het.
 .  .  .  .TIMP1 nt 323 X C: 0.966 28 1.000 44 0 0.953 61 0.950 38 0.023 M: 1.0000
 .  .  .  .T: 0.034 1 0.000 0 0.047 3 0.050 2 F: 0.2238
 .  .  .  .TIMP1 nt 434 X C: 0.483 14 0.273 12 0.157 0.578 37 0.625 25 0.107 M: 0.5005
 .  .  .  .T: 0.517 15 0.727 32 0.422 27 0.375 15 F: 0.0019
 .  .  .  .TIMP2 nt 306 17 C: 0.931 54 0.977 43 0.157 0.961 123 0.975 39 0.071 M: 0.6089
 .  .  .  .T: 0.069 4 0.023 1 0.039 5 0.025 1 F: 1.0000
 .  .  .  .TIMP3 nt 573 17 G: 0.793 46 0.886 39 0.212 0.914 117 0.950 38 0.155 M: 0.0374
 .  .  .  .A: 0.207 12 0.114 5 0.086 11 0.050 2 F: 0.4370
a Chromosomal localization of the gene.
b  .Twenty-nine controls were males and 22 were females all 51 were from the US .
c  . Sixty-four AAA patients were males 21 US, 17 Belgian, 13 Canadian, 7 Swedish, 3 British and 3 Finnish and 20 were females 11 US, 6
.Canadian, 2 Finnish and one Italian .
d Numbers in parentheses indicate number of alleles observed. M, males; F, females.
eObserved heterozygosity. For TIMP1, calculated using female alleles only.
fComparison of allele frequencies between control and AAA groups using Fischer’s exact test.
No significant differences in the frequencies of the nt
323 polymorphism were found between controls and
AAA patients. The frequencies between the two fe-
male groups were, however, significantly different P
.s0.0019 for the nt 434 polymorphism.
The TIMP2 gene contains five exons Hammani et
.al., 1996 , and the sequence variants are in exons 1
and 3. The TIMP2 sequence variants were polymor-
phisms with minor allele frequencies of 0.049 and
 .0.167 for the nt 306 and nt 573, respectively Table 1 ,
with no significant differences between the controls
and the AAA group with nt 306 polymorphism. The
frequencies of nt 573 polymorphism were different
between the control and AAA groups in males. In
further analyses with 30 additional US control individ-
uals, and by dividing the groups according to ethnic
origin, the frequencies remained significantly differ-
 .ent in males Table 2 . Among the US males, the
difference between controls and AAA patients was
 .even more significant Table 2 .
In summary, no mutations were found in the TIMP1
and TIMP2 genes in aneurysm patients. The differ-
ences in allele frequencies of nt 573 TIMP2 polymor-
phism between the control and AAA groups are inter-
esting preliminary findings that need further follow-up
with larger groups and carefully selected control
groups for each ethnic group. It is possible that a
mutation in the TIMP1 or TIMP2 gene contributes to
Table 2
Comparison of the allele frequencies for TIMP2 nt 573 polymorphism
a bEthinicity Controls Unrelated AAA patients
c c c c dM F M F P-value
 .  .  .  .US G: 0.804 74 0.861 62 0.976 41 1.000 22 M: 0.0174
 .  .  .  .A: 0.196 18 0.139 10 0.024 1 0.000 0 F: 0.1098
MqF: 0.0033
e .  .Others G: 0.884 76 0.889 16 M: 0.2122
e .  .A: 0.116 10 0.111 2 F: 1.0000
 .  .  .  .Total G: 0.804 74 0.861 62 0.914 117 0.950 38 M: 0.0300
 .  .  .  .A: 0.196 18 0.139 10 0.086 11 0.050 2 F: 0.2549
MqF: 0.0156
a Eighty-two US American control individuals, 36 females and 46 males.
b For details, see Table 1.
c Numbers in parentheses indicate number of alleles observed. M, males, F, females.
dComparison of allele frequencies between control and AAA groups using Fisher’s exact test.
eComparison across populations may not be valid due to allele frequency differences; however, it is evident that adding the non-US patients to
the total does not inflate the P-values; rather, it is conservative.
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the disease process in patients with aneurysms. Such
mutations could be either mutations in the promoter
sequence or large-scale rearrangements in the
genome, not easily detected by direct sequencing of
RT-PCR products.
The polymorphisms will also be useful for genetic
analyses in other diseases. For example TIMP2 is a
candidate gene for autosomal-dominant retinitis pig-
 .mentosa Bardien et al., 1995 , and altered activities
have been reported in tumor tissues Bramhall et al.,
.1997 .
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